Ekaterina V Fedorova1, Sheree M Schrager2, Lucy F Robinson3, Alexis M Roth1, Carolyn F Wong4,5,6, Ellen Iverson4,5, Stephen E Lankenau1. 1. Department of Community Health and Prevention, Dornsife School of Public Health, Drexel University, Philadelphia, USA. 2. Department of Research and Sponsored Programs, California State University Northridge, Los Angeles, USA. 3. Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, USA. 4. Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, USA. 5. Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, USA. 6. Division of Research on Children, Youth, and Families, Children's Hospital Los Angeles, Los Angeles, USA.
Abstract
INTRODUCTION AND AIMS: Young adults have the highest rates of drug use and contribute significantly to the growing population of medical cannabis patients (MCP). This study examined relationships between longitudinal patterns of illicit/prescription drug use/misuse and cannabis practices among young adult cannabis users. DESIGN AND METHODS: In 2014-2015, 210 young adult MCP and 156 nonpatient users were recruited in Los Angeles and surveyed annually over four waves. The analytical sample was limited to completers of all four waves (n = 301). Distinct developmental trajectories of illicit drug use and prescription drug misuse were identified. Fixed effects regression analysis evaluated changes in cannabis practices by trajectory groups. RESULTS: Results supported two-trajectory solutions (high/low) for illicit drug use and prescription drug misuse. Decreases in use within all four trajectories occurred by wave 4. Low illicit drug use trajectory members were more likely to self-report medical cannabis use. Membership in both types of high-use trajectories was associated with use of concentrates and edibles. The prevalence of MCP, edibles use and cannabis days decreased significantly by wave 4. DISCUSSION AND CONCLUSIONS: While alternative cannabis forms use was associated with membership in high drug use trajectories, self-reported medical cannabis use (not MCP) was negatively associated with high illicit drug use trajectory membership. Reductions in the prevalence of MCP, cannabis days, edibles use and other drug use by wave 4 alongside stable levels of self-reported medical cannabis use might reflect the changing legal status of cannabis in California, maturing out phenomenon and safer patterns of cannabis use.
INTRODUCTION AND AIMS: Young adults have the highest rates of drug use and contribute significantly to the growing population of medical cannabis patients (MCP). This study examined relationships between longitudinal patterns of illicit/prescription drug use/misuse and cannabis practices among young adult cannabis users. DESIGN AND METHODS: In 2014-2015, 210 young adult MCP and 156 nonpatient users were recruited in Los Angeles and surveyed annually over four waves. The analytical sample was limited to completers of all four waves (n = 301). Distinct developmental trajectories of illicit drug use and prescription drug misuse were identified. Fixed effects regression analysis evaluated changes in cannabis practices by trajectory groups. RESULTS: Results supported two-trajectory solutions (high/low) for illicit drug use and prescription drug misuse. Decreases in use within all four trajectories occurred by wave 4. Low illicit drug use trajectory members were more likely to self-report medical cannabis use. Membership in both types of high-use trajectories was associated with use of concentrates and edibles. The prevalence of MCP, edibles use and cannabis days decreased significantly by wave 4. DISCUSSION AND CONCLUSIONS: While alternative cannabis forms use was associated with membership in high drug use trajectories, self-reported medical cannabis use (not MCP) was negatively associated with high illicit drug use trajectory membership. Reductions in the prevalence of MCP, cannabis days, edibles use and other drug use by wave 4 alongside stable levels of self-reported medical cannabis use might reflect the changing legal status of cannabis in California, maturing out phenomenon and safer patterns of cannabis use.
Authors: Jie Guo; Ick-Joong Chung; Karl G Hill; J David Hawkins; Richard F Catalano; Robert D Abbott Journal: J Adolesc Health Date: 2002-10 Impact factor: 5.012
Authors: Stefan G Kertesz; Yulia Khodneva; Joshua Richman; Jalie A Tucker; Monika M Safford; Bobby Jones; Joseph Schumacher; Mark J Pletcher Journal: J Gen Intern Med Date: 2012-01-25 Impact factor: 5.128
Authors: Andrew Smirnov; Jake M Najman; Reza Hayatbakhsh; Maria Plotnikova; Helene Wells; Margot Legosz; Robert Kemp Journal: Addict Behav Date: 2013-07-03 Impact factor: 3.913
Authors: Mark A Ilgen; Kipling Bohnert; Felicia Kleinberg; Mary Jannausch; Amy S B Bohnert; Maureen Walton; Frederic C Blow Journal: Drug Alcohol Depend Date: 2013-05-15 Impact factor: 4.492
Authors: Sean Esteban McCabe; Deborah D Kloska; Philip Veliz; Justin Jager; John E Schulenberg Journal: Addiction Date: 2016-08-09 Impact factor: 6.526
Authors: Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau Journal: Drug Alcohol Depend Date: 2021-02-22 Impact factor: 4.492